(Q60180032)

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Treatment with an anabolic-androgenic steroid affects anxiety-related behavior and alters the sensitivity of cortical GABAA receptors in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Poststeroid balance disorder--a case report in a body builder

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Membrane peptidases in the pig choroid plexus and on other cell surfaces in contact with the cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Effects of sequential removal of rats from a group cage, and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periaqueductal grey and limbic regions.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Violence Toward Women and Illicit Androgenic-Anabolic Steroid Use

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Altered nociception, analgesia and aggression in mice lacking the receptor for substance P

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Age-, sex-, and gonadal steroid-related changes in immunoreactive substance P in the rat anterior pituitary gland.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Substance K and substance P differentially modulate mesolimbic and mesocortical systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Reversed-phase high-performance liquid chromatography combined with tandem mass spectrometry in studies of a substance P-converting enzyme from human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

The substance P fragment SP(1-7) stimulates motor behavior and nigral dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

The substance P(1–7) fragment is a potent modulator of substance P actions in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Sequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Anabolic androgenic steroids increase beta-endorphin levels in the ventral tegmental area in the male rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

The effect on opioid peptides in the rat brain, after chronic treatment with the anabolic androgenic steroid, nandrolone decanoate

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

The role of dorsal striatal GABA(A) receptors in dopamine agonist-induced behavior and neuropeptide gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

The dopaminergic, glutamatergic, GABAergic bases for the action of amphetamine and cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Behavioral analysis of the effect of substance P injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Doping among high school students in Uppsala, Sweden: A presentation of the attitudes, distribution, side effects, and extent of use

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Factors associated with adolescent use of doping agents: anabolic-androgenic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Cellular and molecular mechanisms of drug dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Substance P-(1-7), a substance P metabolite, inhibits withdrawal jumping in morphine-dependent mice

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

1 reference

7 January 2021

Substance P receptors: Localization by light microscopic autoradiography in rat brain using [3H]SP as the radioligand

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Manifestation of severe coronary heart disease after anabolic drug abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Decreased neuropeptide-converting enzyme activities in cerebrospinal fluid during acute but not chronic phases of collagen induced arthritis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Anabolic steroid use among adolescents in Nebraska schools

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Alteration of substance P after trauma to the spinal cord: an experimental study in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Neuropharmacology of brain-stimulation-evoked aggression

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Distribution of messenger RNAs encoding enkephalin, substance P, somatostatin, galanin, vasoactive intestinal polypeptide, neuropeptide Y, and calcitonin gene-related peptide in the midbrain periaqueductal grey in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Spatial working memory is preserved in rats treated with anabolic-androgenic steroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Anabolic steroid use by adolescents: prevalence, motives, and knowledge of risks.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Facilitation of memory by peripheral administration of substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

The rising sun shines on substance P and related peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

The use and misuse of androgens

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Androgen abuse by athletes

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

Neurokinin-1 expression and co-localization with glutamate and GABA in the hypothalamus of the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021

An N-terminal fragment of substance P, substance P(1-7), down-regulates neurokinin-1 binding in the mouse spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900218-7

7 January 2021